Total liabilities of Indofarma FY 2019-2022
At the end of financial year 2022, PT Indofarma (Persero), Tbk recorded total liabilities of approximately 1.45 trillion Indonesian rupiah, indicating a decrease compared to the previous year. The company is a subsidiary of PT Bio Farma (Persero), a state-owned pharmaceutical enterprise, and one of the leading companies in the pharmaceutical industry in Indonesia.